Adherex Technologies (FENC)
(Delayed Data from NSDQ)
$5.57 USD
+0.04 (0.72%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $5.56 -0.01 (-0.18%) 7:58 PM ET
5-Strong Sell of 5 5
C Value A Growth B Momentum A VGM
Brokerage Reports
Adherex Technologies Inc. [FENC]
Reports for Purchase
Showing records 1 - 20 ( 108 total )
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
A New Captain to Steer PEDMARK Back to Growth
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
Product Sales Miss Forecast; 1Q24 Financials; Lowering PT to $15
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
PEDMARQSI Licensing Deal; Revenue Beat and Solid Outlook; Raising PT to $18
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
Optimized Entry and Exit Levels for FENC 112123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
Top, Bottom-Line Beat; Nearing Break-Even; 3Q23 Financials; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
Top and Bottom-Line Miss; 2Q23 Financial Results: Modulating PT to $17
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
PEDMARQSI Approved in Europe; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
PEDMARQSI Receives Positive European Opinion; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
PEDMARK Commercialization on Track; 2022 Financials; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R